Wegman Toby

Avg. Two Year Performance

No purchase track record
(46%) Avg. Sale Return
(21%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(7%)(14%)(31%)(21%)(46%)
Sale Success Rate3 of 142 of 143 of 145 of 142 of 14
Drugs » Biotechnology

Director, 10% Owner:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--